Abstract : Breast diseases include benign inflammatory disorders and fatal invasive cancers. This research examines breast disease trends in Al Elwiyah early breast cancer screening patients over 35. This research used March–September 2022 Baghdad Al-Elwiya Maternity Teaching Hospital women's health centre data. 150 over-35 female recordings were randomly selected. Utilizing BI-RADS breast density classification, 2013 mammography data split patients into two groups: Group I type A+B (fatty, scattered fibroglandular) or (Non-dense) and Group II type C+D. (heterogeneously dense, dense, or dense). All hospital records included age, weight (kg), height (cm), BMI (kg/m2), parity, menarche year, breast feeding duration, ultimate diagnosis, and other information. Most patients (41.3%) are 40-49 years old, 50.7% of females are overweight, 52.7% have 1-3 infants, 42.7% breastfeed for less than 6 months, 78% are married, 38% have category 1 BIRAD of mammography, 36.7% have category 2 of ultrasonography, and 57.1% have substantial malignant lesion. Cytology and histology identify all malignancies, whereas US and mammography detect 60.9 percent of benign tumours. No BMI-diagnosis link (BMI). Long-term contraception and age 50–59 cause cancer. Diagnosis, parity, and breastfeeding length are unrelated. Most breast problems are benign. Fibroadenoma is more common in younger persons. Mastalgia and breast mass rule out malignancy. Most breast complaints in young women are caused by benign disorders that may be treated, however precancerous tendencies may need close monitoring.